These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Advances in haploidentical stem cell transplantation for hematologic malignancies. Montoro J; Sanz J; Sanz GF; Sanz MA Leuk Lymphoma; 2016 Aug; 57(8):1766-75. PubMed ID: 27424663 [TBL] [Abstract][Full Text] [Related]
5. Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia. Kim H; Im HJ; Koh KN; Kang SH; Yoo JW; Choi ES; Cho YU; Jang S; Park CJ; Seo JJ Biol Blood Marrow Transplant; 2019 May; 25(5):965-974. PubMed ID: 30639824 [TBL] [Abstract][Full Text] [Related]
6. Who is the best donor for haploidentical stem cell transplantation? Kongtim P; Ciurea SO Semin Hematol; 2019 Jul; 56(3):194-200. PubMed ID: 31202430 [TBL] [Abstract][Full Text] [Related]
7. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963 [TBL] [Abstract][Full Text] [Related]
8. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial. Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958 [TBL] [Abstract][Full Text] [Related]
9. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia. How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457 [TBL] [Abstract][Full Text] [Related]
10. Evolution of the role of haploidentical stem cell transplantation: past, present, and future. Kwon M; Bailén R; Díez-Martín JL Expert Rev Hematol; 2020 Aug; 13(8):835-850. PubMed ID: 32749913 [TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic stem-cell transplantation from haploidentical donors using 'ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review. González-Vicent M; Díaz Perez MA Curr Opin Oncol; 2018 Nov; 30(6):396-401. PubMed ID: 30307414 [TBL] [Abstract][Full Text] [Related]
12. Is human leukocyte antigen-matched sibling donor transplant always better than haploidentical allograft? Chang YJ; Huang XJ Semin Hematol; 2019 Jul; 56(3):201-208. PubMed ID: 31202431 [TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Kuball J; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M Bone Marrow Transplant; 2016 Jun; 51(6):786-92. PubMed ID: 26901709 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go. Lv M; Huang XJ J Hematol Oncol; 2012 Mar; 5():10. PubMed ID: 22424172 [TBL] [Abstract][Full Text] [Related]
15. Halfway there: the past, present and future of haploidentical transplantation. Slade M; Fakhri B; Savani BN; Romee R Bone Marrow Transplant; 2017 Jan; 52(1):1-6. PubMed ID: 27454072 [TBL] [Abstract][Full Text] [Related]
16. Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure. Knüppel E; Medinger M; Stehle G; Infanti L; Halter J; Burkhalter F; Mujagic E; Heim D; Passweg J Ann Hematol; 2017 Apr; 96(4):703-705. PubMed ID: 28160086 [No Abstract] [Full Text] [Related]
17. Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review. Rashidi A; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Cashen AF; Fehniger TA; Romee R Biol Blood Marrow Transplant; 2016 Sep; 22(9):1696-1701. PubMed ID: 27223108 [TBL] [Abstract][Full Text] [Related]
19. A review of hematopoietic cell transplantation in China: data and trends during 2008-2016. Xu LP; Wu DP; Han MZ; Huang H; Liu QF; Liu DH; Sun ZM; Xia LH; Chen J; Wang HX; Wang C; Li CF; Lai YR; Wang JM; Zhou DB; Chen H; Song YP; Liu T; Liu KY; Huang XJ Bone Marrow Transplant; 2017 Nov; 52(11):1512-1518. PubMed ID: 28436973 [TBL] [Abstract][Full Text] [Related]